In addition to its fibrinolytic effects, which have been previously described, inicarone inhibits platelet adhesiveness and aggregation in animals. It therefore possesses the properties required of an anti-thrombotic agent. Actually, inicarone is able not only to increase the thrombus formation time, but also to lyse experimental thrombus created under severe conditions. It may be therefore reasonably assumed that inicarone could be effective in man in all syndromes involving thrombotic episodes.
Get full access to this article
View all access options for this article.
References
1.
BarchewitzGBrotelleRGuilbertACharlierR (1974) Recherches dans la série des benzofurannes. LV. Propriétés fibrinolytiques de l'inicarone. Thérapie29, 57
2.
BarchewitzGBrotelleRGuilbertAChotardLChartierR (1972) Recherches dans la série des benzofurannes. XLVI. Effet thrombolytique de la benzarone. Arzneimittel Forschung22, 553
3.
BattacharjiSKHutchinsonECMcCallAJ (1967) Stenosis and occlusion of vessels in cerebral infarction. British Medical Journal3, 270
4.
BornGVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature194, 927
5.
BrowseNLHallJH (1969) Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet2, 718
6.
CaenJMichelH (1964) Agrégation des plaquettes à l'ADP (acide adénosine diphosphorique). Revue Fransçaise d'Etudes Cliniques et Biologiques9, 999
7.
CarterAEEbanRPerrettAD (1971) Prevention of post-operative deep-venous thrombosis and pulmonary embolism. British Medical Journal1, 312
8.
ChandlerAB (1958) In vitro thrombotic coagulation of the blood. A method for producing a thrombus. Laboratory Investigations7, 110
9.
ConnorWEHPooleJCF (1961) The effect of fatty acids on the formation of thrombi. Quarterly Journal of Experimental Physiology46, 1
10.
DuguidJB (1949) Pathogenesis of atherosclerosis. Lancet1, 925
FlancCKakkarVVClarkeMB (1968) The detection of venous thrombosis of the legs using 125I-labelled fibrinogen. British Journal of Surgery55, 742
13.
GallusASHirschJTuttleRJTrebilcockRO'BrienSECarrollJJMindenJHHudeckiSM (1973) Small subcutaneous doses of heparin in prevention of venous thrombosis. New England Journal of Medicine288, 545
14.
GrosgogeatYGratadourC (1972) Anatomo-pathologie et physiopathologie de l'athérosclérose oblitérante des membres inférieurs. Revue du Praticien22, 3965
15.
HamptonJ (1971) Trends in the development of anti-thrombotic agents. American Journal of Cardiology27, 659
16.
KakkarVVFieldESNicolaidesANFlutePT (1971) Low doses of heparin in prevention of deep-vein thrombosis. Lancet2, 669
17.
KakkarVVHoweCTFlancCClarkeMB (1969) Natural history of post-operative deep-vein thrombosis. Lancet2, 230
18.
KakkarVVSpindlerJFlutePTCorringanTFossardDPCrellinRQWesslerSYinET (1972) Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. Lancet2, 101
19.
LambyeJMMabaffyRGBarberDCKarmodyAMScottMMMathesonNA (1970) Diagnostic accuracy in venous thrombosis. British Medical Journal2, 142
20.
MirouzeJMaryP (1968) Angiopathie diabétique. Revue du Praticien18, 3735
NegusDPintoDJBrownN (1969) Platelet adhesiveness in post-operative deep-vein thrombosis. Lancet1, 220
23.
NegusDPintoDJLe QuesneLPBrownNChapmanM (1968) 125I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography. British Journal of Surgery55, 835
24.
PooleJCF (1959) A study of artificial thrombi produced by a modification of Chandler's method. Quarterly Journal of Experimental Physiology44, 24
25.
PooleJCF (1960) Methods of observing thrombosis in vitro. Proceedings of the Royal Society of Medicine53, 22
26.
RabyC (1966) Biologie des hémorragies et des thromboses (Masson, Paris)
27.
RoschlauWHEPainterRH (1962) Human fibrinolysis with and without urokinase: its effect on experimental arterial thrombi in dogs. Canadian Journal of Biochemistry and Physiology40, 1919
28.
SamamaMBilski-PasquierG (1972) Les traitements thrombolytiques. Revue du Praticien22, 96
29.
SamamaMDesnoyersPConardJLabaumeJ (1969) La thrombolyse par la streptokinase. Première partie. Etude expérimentale chez l'animal. Coagulation2, 153
30.
SevinR (1971) Diabetic retinopathy—New pathogenic concepts. Advances in Ophthalmology24, 315
31.
SevittNGGallagherNG (1959) Prevention of venous thrombosis and pulmonary embolism in injured patients. Lancet2, 981
32.
SharnoffJGde BlasioG (1970) Prevention of fatal post-operative thromboembolism by heparin. Lancet2, 1006
33.
SherryS (1972) Prospects in anti-thrombotic therapy. American Journal of Cardiology29, 81
34.
ThibaultP (1972) Thromboses post-opératoires. Prévention par de faibles doses d'héparine sous-cutanée. Nouvelle Presse Médicale1, 2915
